The Chemours Company (CC) FY2026 Q2 P&L / Income Statement

The Chemours Company (CC) FY2026 Q2 P&L / Income Statement

Income statement for 2026-04-01 through 2026-06-30. View: Statement Geographical by Timing Of Transfer Of Good Or Service. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Net sales

1,591,000,000 US dollars

Cost of goods sold

1,305,000,000 US dollars

Gross profit

286,000,000 US dollars

Total other operating expenses

499,000,000 US dollars

Operating profit (calculated)

negative 213,000,000 US dollars

Other income (expense), net (calculated)

212,000,000 US dollars

Loss before income taxes

negative 1,000,000 US dollars

Provision for income taxes

273,000,000 US dollars

Net loss

negative 274,000,000 US dollars

Asia Pacific - Transferred at a Point in Time

317,000,000 US dollars

Latin America - Transferred at a Point in Time

208,000,000 US dollars

North America - Transferred at a Point in Time

754,000,000 US dollars

Europe, the Middle East, and Africa - Transferred at a Point in Time

312,000,000 US dollars

Selling, general, and administrative expense

469,000,000 US dollars

Research and development expense

27,000,000 US dollars

Restructuring, asset-related, and other charges

3,000,000 US dollars

Chart connections

• Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.